Armistice Capital, LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $6.02 Billion distributed in 259 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Ptc Therapeutics, Inc. with a value of $268M, Supernus Pharmaceuticals, Inc. with a value of $159M, Incyte Corp with a value of $145M, Travere Therapeutics, Inc. with a value of $107M, and Cytokinetics Inc with a value of $100M.
Examining the 13F form we can see an decrease of $1.66B in the current position value, from $7.69B to 6.02B.
Armistice Capital, LLC is based out at New York, NY
Below you can find more details about Armistice Capital, LLC portfolio as well as his latest detailed transactions.
